29.954.28% ( -1.34 )
Delay Closed: Nov 13, 15:00:00Financials
Q3 2026 Earnings
Financial report interval: 2026.06.30 - 2026.09.30
Overview: Hicin Pharmaceutical(300584) the Revenue is 251.13 M (+54.11%);the EBIT is 63.03 M (+255%);the EPS is 0.252 (+757.9%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.25B54.11%
----
----
EBIT
0.06B255.02%
----
----
EPS
0.2516757.91%
----
----
Revenue
ActualEstimateUnit: CNY
Quarterly
EBIT
ActualEstimateUnit: CNY
Quarterly
Net income
ActualEstimateUnit: CNY
Quarterly
EPS
ActualEstimateUnit: CNY
Quarterly
